title: Psoriatic Arthritis Registries.
abstract: The introduction of new biological drugs for the treatment of rheumatoid arthritis and spondyloarthritis has led to the creation of a number of registries in Europe and the United States. Most of them are sponsored by national rheumatology societies, and provide information that is useful in clinical practice concerning the clinical characteristics, efficacy, and safety of all licensed biological drugs. Their findings also help to improve our understanding of the quality of life and working ability of patients receiving biological drugs, and suggest methods for allocating resources. However, there are only a few registries for psoriatic arthritis, and efforts should be made to increase their number to obtain further reliable and useful data.
authors.affiliation: From the Rheumatology Unit, L. Sacco University Hospital, and the Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Galeazzi Orthopedic Institute, Milan; and the Rheumatology Unit, San Giovanni di Dio Hospital, Florence, Italy.P. Sarzi-Puttini, MD, PhD, Consultant Rheumatologist and Head of Rheumatology Unit; V. Varisco, MD, Resident in Rheumatology; M.C. Ditto, MD, Specialist Rheumatologist, Rheumatology Unit, L. Sacco University Hospital; M. Benucci, MD, Consultant Rheumatologist, Rheumatology Unit, San Giovanni di Dio Hospital; F. Atzeni, MD, PhD, Clinical Research in Rheumatology, IRCCS Galeazzi Orthopedic Institute.
authors.forename: Piercarlo
authors.initials: P
authors.lastname: Sarzi-Puttini
authors.affiliation: From the Rheumatology Unit, L. Sacco University Hospital, and the Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Galeazzi Orthopedic Institute, Milan; and the Rheumatology Unit, San Giovanni di Dio Hospital, Florence, Italy.P. Sarzi-Puttini, MD, PhD, Consultant Rheumatologist and Head of Rheumatology Unit; V. Varisco, MD, Resident in Rheumatology; M.C. Ditto, MD, Specialist Rheumatologist, Rheumatology Unit, L. Sacco University Hospital; M. Benucci, MD, Consultant Rheumatologist, Rheumatology Unit, San Giovanni di Dio Hospital; F. Atzeni, MD, PhD, Clinical Research in Rheumatology, IRCCS Galeazzi Orthopedic Institute.
authors.forename: Valentina
authors.initials: V
authors.lastname: Varisco
authors.affiliation: From the Rheumatology Unit, L. Sacco University Hospital, and the Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Galeazzi Orthopedic Institute, Milan; and the Rheumatology Unit, San Giovanni di Dio Hospital, Florence, Italy.P. Sarzi-Puttini, MD, PhD, Consultant Rheumatologist and Head of Rheumatology Unit; V. Varisco, MD, Resident in Rheumatology; M.C. Ditto, MD, Specialist Rheumatologist, Rheumatology Unit, L. Sacco University Hospital; M. Benucci, MD, Consultant Rheumatologist, Rheumatology Unit, San Giovanni di Dio Hospital; F. Atzeni, MD, PhD, Clinical Research in Rheumatology, IRCCS Galeazzi Orthopedic Institute.
authors.forename: Maria Chiara
authors.initials: MC
authors.lastname: Ditto
authors.affiliation: From the Rheumatology Unit, L. Sacco University Hospital, and the Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Galeazzi Orthopedic Institute, Milan; and the Rheumatology Unit, San Giovanni di Dio Hospital, Florence, Italy.P. Sarzi-Puttini, MD, PhD, Consultant Rheumatologist and Head of Rheumatology Unit; V. Varisco, MD, Resident in Rheumatology; M.C. Ditto, MD, Specialist Rheumatologist, Rheumatology Unit, L. Sacco University Hospital; M. Benucci, MD, Consultant Rheumatologist, Rheumatology Unit, San Giovanni di Dio Hospital; F. Atzeni, MD, PhD, Clinical Research in Rheumatology, IRCCS Galeazzi Orthopedic Institute.
authors.forename: Maurizio
authors.initials: M
authors.lastname: Benucci
authors.affiliation: From the Rheumatology Unit, L. Sacco University Hospital, and the Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Galeazzi Orthopedic Institute, Milan; and the Rheumatology Unit, San Giovanni di Dio Hospital, Florence, Italy.P. Sarzi-Puttini, MD, PhD, Consultant Rheumatologist and Head of Rheumatology Unit; V. Varisco, MD, Resident in Rheumatology; M.C. Ditto, MD, Specialist Rheumatologist, Rheumatology Unit, L. Sacco University Hospital; M. Benucci, MD, Consultant Rheumatologist, Rheumatology Unit, San Giovanni di Dio Hospital; F. Atzeni, MD, PhD, Clinical Research in Rheumatology, IRCCS Galeazzi Orthopedic Institute. atzenifabiola@hotmail.com.
authors.forename: Fabiola
authors.initials: F
authors.lastname: Atzeni
mesh_terms: D015535:Arthritis, Psoriatic / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology; D001688:Biological Products / Q000009:adverse effects / Q000627:therapeutic use*; D003299:Cooperative Behavior; D004185:Disability Evaluation; D019317:Evidence-Based Medicine; D006301:Health Services Needs and Demand; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007391:International Cooperation; D020380:Needs Assessment; D011788:Quality of Life; D012042:Registries; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D001688:Biological Products; D007166:Immunosuppressive Agents
keywords: ADVERSE EVENTS; BIOLOGICAL DRUGS; PSORIATIC ARTHRITIS; REGISTRIES